Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit

Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit

Metformin is the first-line medication for type 2 diabetes, but it also has a long history of improved outcomes in infectious diseases, such as influenza, hepatitis C, and in-vitro assays of zika. In the current Covid-19 pandemic, which has rapidly spread throughout the world, 4 observational studie...

Full description

Bibliographic Details
Main Authors: Sherehan Ibrahim, Jamie R. Lowe, Carolyn T. Bramante, Surbhi Shah, Nichole R. Klatt, Nancy Sherwood, Louis Aronne, Michael Puskarich, Leonardo Tamariz, Ana Palacio, Eric Bomberg, Michael Usher, Samantha King, Brad Benson, Deneen Vojta, Chris Tignanelli, Nicholas Ingraham
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Endocrinology
Subjects:
metformin
COVID-19
mechanisms of action
obesity
microbiome
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.587801/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.587801/full

Similar Items